lh e present measures adopted to prevent transfusion-associated Chagas' disease include screening o f blood donors. ancl/or the inactivation q/'T. cruzi in collected blood using gentian violet (GV). as a tiypanocidal agent. ín this study, ive investigated the efficacy of the com biued use o f AM T a n d UV-A in inactirating T. cruzi in infected h u m a n platelet cuncentrates. H um an platelet concentrates were infected u ith T. cruzi (2x1 (T7ml) o f the Y strain. transfered to PL 269 (Fenwal Laboratories) containers. a n d treated
American trypanosomiasis (Chagas' disease) is a zoonosis caused by the protozoan parasite
Trypanosoma cruzi ( T. cruzi). It has been
estimated that approximately 60% of the 18 million people infected with T. cruzi have migrated from rural endemic areas of Latin America to urban areas of endemic and nonendemic countries1 7. Since most of these individuais are silent chronic carriers they potentially jeopardize the local blood supply, and blood recipients are still being infected by
T. cruzi.
The prevention of the transfusionassociated Chagas' disease (TA-CD) has been done by clinicai and serological screening of blood donors12, and/or inativation of T. cruzi in collected blood using gentian violet (GV) as a trypanocidal agent6.
Recently, the combination of ultraviolet light (UV-A) and am inom ethyltrim ethyl psoralen (AMT) has been shown to be able to inactivate virus infecting cellular blood products'. In this study, vve investigated the efficacy of the combinecl use of AMT and UV-A in inactivating T. cruzi in contaminated human platelet concentrates.
MATERIAL AND M ETHODS
Human platelet concentrates were infected with T. cruzi of the Y strain (2 x 10" parasites per ml), transferred into UV-permeable platelet storage PL269 containers (Baxter Health Corporation, Fenwal Division) and treated under one of the following conditions: 1) Untreated 2) GV (250pg/ml) + Ascorbic Acid (lmg/ml) 3) GV ((250pg/ml) + Ascorbic Acid (lmg/ml) + UV-A 4) GV (250pg/ml) + UV-A 5) AMT (40pg/ml) + Ascorbic Acid (lmg/ml) 6) AMT (40pg/ml) + Ascorbic Acid (lmg/ml) + UV-A 
7) AMT (40pg/m l) + UV-A 8) UV-A only
The UV-A irradiation was delivered at doses of eitlier 24, 92, 184, 276, 368, or 644kJ/m2 using a prototype ultraviolet irradiator (Fenwal Laboratories) containing two banks of six UV-A bulbs (I3LE-1T151); (Spectronics Corporation).
The microscopic examination of active circulating forms of T. c r u z i in platelet su.spension.s was p erfo rm ed using the m icrohem atocrit tech n iq u e1 ' at 1, 6, and 24 hours after protocol incubation.
RESULTS
As expected, the inactivation of T. c ru zi parasites as defined by absence of active circulating parasites, was observed in ali platelet concentrates treated with protocols containing GV (protocols 2, 3 and 4) immediately after 1 hour of treatment incubation. This T. c r u z i inactivation was confinned by animal experiments in which Swiss in ice inoculated with platelet suspensions submitted to such treatment protocols did not develop a T. c ru zi infection.
In contrast, active forms of T. c ru zi were observed, until after 24 hours of incubation, in platelet concentrates left untreated (protocol 1); treated with AMT plus AA (protocol 5); or treated with UV-A without association with GV (protocols 6, 7 and 8).
The results of the study are summarized in Table 1 .
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DISCUSSION
Allogeneic blood transfusion is the main route of transmission of Chagas' disease in urban area:; of botli endemic and non-endemic countries. The exclusion of donors who immigrated from endemic areas by using a questionnaire can significantly reduce the blood supply in certain areas. Moreover, the serologic diagnosis of Chagas' disease is complex yielcling both false positive and false negative results. Thus, the investigation of methods to inactivate T. c ru zi tliat might be present in blood produet is essential. We could show recently. that the association of GV, AA and photoirradiation w ith visible light efficiently sterilized T. cnízi-infected blood after treatment incubation time shorter than 30 minutes\ In the present studv, we investigated the effectiveness of the combination of AMT and UV-A irradiation in inactivating T. c r u z i in contaminated human platelet concentrates, since it has been demonstrated, in a rabbit model, that AMT/UV-A treated platelet suspensions retain hemostatic function".
The data from our experiments confirm the trypanocidal activity of the gentian violet, alone or combined with ascorbic acid. In contrast, identical numbers of active circulating forms of T. c ru zi were observed under ali treatment conditions including the various doses of UV-A irradiation ranging from 24 to 644 kJ/nV. The present data provide evidence. therefore, of the lack of trypanocidal activity of AMT and UV-A in inactivating T. c ru zi present in contaminated human platelet concentrates.
Against our results, Gottlieb et al3 showed that AMT together with UV-A were able to inactivate 5 log of T. c r u z i in platelet concentrates.
Further studies are being developed in our laboratory in order to elucidate the role of UV-A in T. c ru zi inactivation. 
RESUMO

As medidas adotadas atualm ente para prevenir a doença de Chagas transfusional incluem a seleção dos doadores de sangue e/ou a inativaçâo do T. cruzi no sangue coletado através do uso da violeta de genciana (VG) como agente tripanosomicida. Neste estudo, nós investigamos a eficácia do uso com binado do A M T e da UV-A para a neutralização doT. cruzi em concentrados d ep laquetas h u m a n a s infectados. Os concentrados de plaquetas infectados com cepa Y de T. cruzi (Zxl(T/m l) foram transferidos para recipientes PI. 269 (Fenwal Laboratories) e tratados com VG (250/ig/m lj e ácido ascórbico (Im g/inlj; VG. ácido ascórbico e UV-A; G V e U\'-A; Nota Prévia. M oraes-Souza H, Bordin JO, Bardossy L, Blajchm an MA. Treatment o f T. cru zi infected h u m a n platelet concentrates with am inom ethyltrim ethyl psoralen (AMT) a n d ultraviolet A (UV-A) light: prelim inary results. Revista da Sociedade Brasileira de M edicina
